Study on hepatic differentiation of mesenchymal stem cells derived from human umbilical cord blood, and cell therapy for liver disease by use of mesenchymal stem cells.
Study on hepatic differentiation of mesenchymal stem cells derived from human umbilical cord blood, and cell therapy for liver disease by use of mesenchymal stem cells.
批准号:
17590625
负责人:
CHEN Cheng-Hsin
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In this grant in aid for scientific research, we carried out a research project on therapeutic-model development of cell transplantation for liver disease by use of mesenchymal stem cells derived from human umbilical cord blood (CB-MSC).At first, we established a stable cell line of CB-MSC under our original culture condition supplement with fibroblast growth factor-2 (FGF-2), and succeeded to culture these cells in long term. The cell surface markers of our CB-MSC were confirmed to be similar to those of previous reports.Next, we tried to differentiate CB-MSC cell line into mature hepatocytes. In order to induce maturation, FGF-2 was removed from media, and the medium was supplemented with EHS gel. After the maturation step, CB-MSC was induced to express hepatic markers, such as glutamine synthetase and tyrosine amino-transferase (TAT). Additionally, we constructed retroviral vector expressing hepatic nuclear factor-4 (HNF-4), then, CB-MSC was infected with the retrovirus. HNF-4 expressing CB-MSC also expressed the transcripts of TAT.Finally, we tested cell transplantation of CB-MSC into chronically liver-injured mice. We employed immunodeficient (SCID) mice damaged chronically by a urokinase-type plasminogen activator transgene under a control of albumin promotor/enhancer (ALB-uPA/SCID mice). These mice were kindly provided from the Yoshizato Project, Cooperative Link of Unique Science and Technology for Economy Revitalization. The transplanted cord blood cells engrafted in the liver of ALB-uPA/SCID mice more efficiently than previously reported mouse-models. The engrafted CB cells exhibited the similar phenotype of functional hepatocytes.Our results suggested that human cord blood can supply the transplantable hepatic cells for liver disease. The outcome of the research project will be a basis of liver regenerative medicine, and we think the purpose of this grant in aid for scientific research was accomplished.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
がん幹細胞 : 新規治療開発への展望
癌症干细胞:新疗法开发的前景
DOI:
--
发表时间:
2006
期刊:
医学のあゆみ (掲載予定)
影响因子:
--
作者:
[柿沼 晴, 他]
通讯作者:
他
ヒト臍帯血細胞の肝細胞への誘導と細胞移植
人脐带血细胞诱导成肝细胞及细胞移植
DOI:
--
发表时间:
2006
期刊:
炎症・再生 26・1
影响因子:
--
作者:
[Koyama T, Sakamoto N, Tanabe Y, Nakagawa M, Itsui Y, et al., 柿沼 晴]
通讯作者:
柿沼 晴
臍帯血由来細胞の機能的肝細胞への誘導(消化器病学の進歩2005-モノグラフ 消化器病学のニコーフロンティア編)
将脐带血来源的细胞诱导为功能性肝细胞(胃肠病学进展2005-尼科胃肠病学前沿专着编辑)
DOI:
--
发表时间:
2005
期刊:
影响因子:
--
作者:
[柿沼 晴, (荒川泰之編・分著)]
通讯作者:
(荒川泰之編・分著)
Mutations in the NS5B region of the hepatitis C virus genome correlate with clinical outcomes of interferon-α plus ribavirin combination therapy.
丙型肝炎病毒基因组 NS5B 区域的突变与干扰素 α 加利巴韦林联合治疗的临床结果相关。
DOI:
--
发表时间:
2005
期刊:
Journal of Gastroenterology and Hepatology 20(9)
影响因子:
--
作者:
[Hamano K, Sakamoto N, Kakinuma S, Watanabe M, et al.]
通讯作者:
et al.
DOI:
10.1111/j.1365-2893.2006.00739.x
发表时间:
2006-09-01
期刊:
JOURNAL OF VIRAL HEPATITIS
影响因子:
2.5
作者:
[Kohashi, T., Maekawa, S., Watanabe, M.]
通讯作者:
Watanabe, M.
共 15 条
海外基金